Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annoor Awadasseid

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2025
Innovations in cancer immunotherapy with PD-1 antibody-drug conjugates and their antitumor mechanismsJianwei Wang, Zeyu Chen, Yanling Wu, et al.
Cancer Management and Research|August 22, 2020
New Advances in Canonical Wnt/β-Catenin Signaling in CancerXiaolan Wen, Yanling Wu, Annoor Awadasseid, et al.
Die Pharmazie|January 4, 2024
Repurposing and discovery of transmembrane serine protease 2 (TMPRSS2) inhibitors as prophylactic therapies for new coronavirus disease 2019 (COVID-19)Hao Yang, Xinxin Lin, Qimeng Yu, et al.
Life Sciences|January 18, 2021
Effect of 4,5-diazafluorene derivative on γδ T cell-mediated cytotoxicity against renal cell carcinomaXiaolan Wen, Yanling Wu, Yoshimasa Tanaka, et al.
Chemmedchem|November 23, 2025
Small-Molecule Inhibitors Targeting PD-1/PD-L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical ProspectsJianwei Wang, Shenwei Yu, Liang Qian, et al.
Chemmedchem|April 17, 2025
Progress in the Research and Development of Biphenyl Small Molecules Targeting PD-1/PD-L1 as Potential Antitumor Drug CandidatesWei He, Haoran Xu, Annoor Awadasseid, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2024
Small molecule and PROTAC molecule experiments in vitro and in vivo, focusing on mouse PD-L1 and human PD-L1 differences as targetsAnnoor Awadasseid, Rui Wang, Shishi Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 4, 2022
Current studies and future promises of PD-1 signal inhibitors in cervical cancer therapyAnnoor Awadasseid, Yongnan Zhou, Koutian Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 6, 2025
Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer ImmunotherapyAnnoor Awadasseid, Mengda Wu, Feng Zhang, et al.
International Journal of Biological Macromolecules|June 30, 2020
Characterization of Camptotheca acuminata 10-hydroxygeraniol oxidoreductase and iridoid synthase and their application in biological preparation of nepetalactol in Escherichia coli featuring NADP<sup>+</sup> - NADPH cofactors recyclingAnnoor Awadasseid, Wei Li, Zhan Liu, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 30, 2025
Innovations in cancer immunotherapy with PD-1 antibody-drug conjugates and their antitumor mechanismsJianwei Wang, Zeyu Chen, Yanling Wu, et al.
Cancer Management and Research|August 22, 2020
New Advances in Canonical Wnt/β-Catenin Signaling in CancerXiaolan Wen, Yanling Wu, Annoor Awadasseid, et al.
Die Pharmazie|January 4, 2024
Repurposing and discovery of transmembrane serine protease 2 (TMPRSS2) inhibitors as prophylactic therapies for new coronavirus disease 2019 (COVID-19)Hao Yang, Xinxin Lin, Qimeng Yu, et al.
Life Sciences|January 18, 2021
Effect of 4,5-diazafluorene derivative on γδ T cell-mediated cytotoxicity against renal cell carcinomaXiaolan Wen, Yanling Wu, Yoshimasa Tanaka, et al.
Chemmedchem|November 23, 2025
Small-Molecule Inhibitors Targeting PD-1/PD-L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical ProspectsJianwei Wang, Shenwei Yu, Liang Qian, et al.
Chemmedchem|April 17, 2025
Progress in the Research and Development of Biphenyl Small Molecules Targeting PD-1/PD-L1 as Potential Antitumor Drug CandidatesWei He, Haoran Xu, Annoor Awadasseid, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 13, 2024
Small molecule and PROTAC molecule experiments in vitro and in vivo, focusing on mouse PD-L1 and human PD-L1 differences as targetsAnnoor Awadasseid, Rui Wang, Shishi Sun, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 4, 2022
Current studies and future promises of PD-1 signal inhibitors in cervical cancer therapyAnnoor Awadasseid, Yongnan Zhou, Koutian Zhang, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 6, 2025
Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer ImmunotherapyAnnoor Awadasseid, Mengda Wu, Feng Zhang, et al.
International Journal of Biological Macromolecules|June 30, 2020
Characterization of Camptotheca acuminata 10-hydroxygeraniol oxidoreductase and iridoid synthase and their application in biological preparation of nepetalactol in Escherichia coli featuring NADP<sup>+</sup> - NADPH cofactors recyclingAnnoor Awadasseid, Wei Li, Zhan Liu, et al.
Pageof 5